Tocilizumab
What's New
Last Posted: Nov 10, 2023
- [Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].
Anne-Marie Knieper, et al. Zeitschrift fur Rheumatologie 2023 0 - The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis.
Jonathan L Ciofani, et al. Scientific reports 2023 0 (1) 18810 - The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China.
Zhou Shu, et al. Frontiers in immunology 2023 0 1267933 - Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis.
Mariko Inoue, et al. Scientific reports 2023 0 (1) 15250 - Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review.
Chang Geng, et al. Journal of neurology 2023 0 - Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis.
Sainz Luis, et al. Journal of personalized medicine 2023 0 (1) - A case of adult onset Still's disease with mutations of the MEFV gene who is partially responsive to colchicine.
Ou-Yang Liang-Jun, et al. Medicine 2018 0 (15) e0333 - Emergent high fatality lung disease in systemic juvenile arthritis.
Saper Vivian E, et al. Annals of the rheumatic diseases 2019 0 (12) 1722-1731 - Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.
Hinze Claas, et al. Arthritis & rheumatology (Hoboken, N.J.) 2019 0 (3) 499-505 - Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Henes Joerg C et al. Journal of clinical medicine 2022 11(18)
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 15, 2024
- Content source: